Second-Generation Androgen Receptor Antagonists as Hormonal Therapeutics for Three Forms of Prostate Cancer

Enzalutamide is the first second-generation nonsteroidal androgen receptor (AR) antagonist with a strong binding affinity to AR. Most significantly, enzalutamide can prolong not only overall survival time and metastatic free survival time for patients with lethal castration-resistant prostate cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Rajaram, Pravien, Rivera, Alyssa, Muthima, Kevin, Olveda, Nicholas, Muchalski, Hubert, Chen, Qiao-Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7287767/
https://www.ncbi.nlm.nih.gov/pubmed/32456317
http://dx.doi.org/10.3390/molecules25102448

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7287767/
https://www.ncbi.nlm.nih.gov/pubmed/32456317
http://dx.doi.org/10.3390/molecules25102448

Ejemplares similares